Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC

INTRODUCTION: With the approval of first-line osimertinib treatment in stage IV EGFR-mutated NSCLC, detection of resistance mechanisms will become increasingly important—and complex. Clear guidelines for analyses of these resistance mechanisms are currently lacking. Here, we provide our recommendati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hondelink, Liesbeth M., Jebbink, Merel, von der Thüsen, Jan H., Cohen, Danielle, Dubbink, Hendrikus J., Paats, Marthe S., Dingemans, Anne-Marie C., de Langen, Adrianus J., Boelens, Mirjam C., Smit, Egbert F., Postmus, Pieter E., van Wezel, Tom, Monkhorst, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608608/
https://www.ncbi.nlm.nih.gov/pubmed/34849493
http://dx.doi.org/10.1016/j.jtocrr.2021.100252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608608/
https://www.ncbi.nlm.nih.gov/pubmed/34849493
http://dx.doi.org/10.1016/j.jtocrr.2021.100252

Ejemplares similares